Fagron N.V.
A global pharmaceutical compounding company focused on personalized medicine.
FAGR | BR
Overview
Corporate Details
- ISIN(s):
- BE0003874915
- LEI:
- 549300TRKRUFK2RRG779
- Country:
- Belgium
- Address:
- Venecoweg 20A, 9810 Nazareth
- Website:
- https://fagron.com/
- Sector:
- Manufacturing
Description
Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2026-01-12 07:56 |
Inside information: Fagron announces the completion of the acquisition of Unive…
|
Dutch | PDF • 51.1 KB | ||
| 2026-01-12 07:56 |
Inside information: Fagron announces the completion of the acquisition of Unive…
|
English | PDF • 170.6 KB | ||
| 2026-01-12 07:37 |
Disclosure of notification received from BNP Paribas
|
Dutch | PDF • 169.5 KB | ||
| 2026-01-12 07:37 |
Disclosure of notification received from BNP Paribas
|
English | PDF • 163.7 KB | ||
| 2026-01-12 07:35 |
Voorkennis: Fagron kondigt de afronding van de overname van University Compound…
|
Dutch | PDF • 51.1 KB | ||
| 2026-01-12 07:35 |
Voorkennis: Fagron kondigt de afronding van de overname van University Compound…
|
Dutch | PDF • 170.0 KB | ||
| 2026-01-12 07:00 |
Fagron announces the completion of the acquisition of University Compounding Ph…
|
English | DOC • 170.6 KB | ||
| 2026-01-12 07:00 |
Fagron kondigt de afronding van de overname van University Compounding Pharmacy…
|
Dutch | DOC • 170.0 KB | ||
| 2026-01-09 17:40 |
Disclosure of notification received from BNP Paribas.pdf
|
English | PDF • 163.7 KB | ||
| 2026-01-09 17:40 |
Openbaarmaking van kennisgeving ontvangen van BNP Paribas.pdf
|
Dutch | PDF • 169.5 KB | ||
| 2026-01-06 07:25 |
Fagron announces the completion of Purifarma
|
Dutch | PDF • 171.8 KB | ||
| 2026-01-06 07:25 |
Fagron announces the completion of Purifarma
|
English | PDF • 165.3 KB | ||
| 2026-01-06 07:00 |
Fagron announces the completion of Purifarma.pdf
|
English | PDF • 165.3 KB | ||
| 2026-01-06 07:00 |
Fagron kondigt de afronding van de overname van Purifarma aan.pdf
|
Dutch | PDF • 171.8 KB | ||
| 2025-12-19 07:49 |
Fagron accelerates global expansion with two strategic acquisitions and a key N…
|
Dutch | PDF • 184.1 KB |
Automate Your Workflow. Get a real-time feed of all Fagron N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fagron N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fagron N.V. via our API.
Peer Companies
